MedTrace Logo

Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients

NCT02044562 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-01-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether dietary nitrate supplementation could improve the plasma nitrate levels for nasopharyngeal carcinoma patients receiving concurrent chemo-radiation therapy.

Conditions

  • Nasopharyngeal Carcinoma

Interventions

DIETARY_SUPPLEMENT

nitrate supplementation

A 70 ml beetroot juice containing 0.45g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.

DIETARY_SUPPLEMENT

Placebo

A 70 ml placebo containing 0 g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Songlin Wang, Ph.D · Professor and Vice President of Capital Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044562 on ClinicalTrials.gov